Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_4
1
6%
Ph not_applicable
4
25%
Ph phase_3
1
6%
Ph early_phase_1
2
13%
Ph phase_1
3
19%
Ph phase_2
5
31%

Phase Distribution

5

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
2(12.5%)
Phase 1Safety & dosage
3(18.8%)
Phase 2Efficacy & side effects
5(31.3%)
Phase 3Large-scale testing
1(6.3%)
Phase 4Post-market surveillance
1(6.3%)
N/ANon-phased studies
4(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
Not yet recruiting2
Enrolling by invitation1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (12.5%)
Phase 13 (18.8%)
Phase 25 (31.3%)
Phase 31 (6.3%)
Phase 41 (6.3%)
N/A4 (25.0%)

Trials by Status

enrolling_by_invitation16%
unknown16%
completed1169%
not_yet_recruiting213%
withdrawn16%

Recent Activity

0 active trials
Showing 5 of 16
not_yet_recruitingphase_4

Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata

NCT07453238
enrolling_by_invitationearly_phase_1

COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

NCT06880042
completedphase_3

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds

NCT00691002
completedphase_2

LEO 90100 in the Treatment of Psoriasis Vulgaris

NCT01536938
not_yet_recruitingnot_applicable

Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses

NCT06685588
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07453238Phase 4

Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata

Not Yet Recruiting
NCT06880042Early Phase 1

COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

Enrolling By Invitation
NCT00691002Phase 3

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds

Completed
NCT01536938Phase 2

LEO 90100 in the Treatment of Psoriasis Vulgaris

Completed
NCT06685588Not Applicable

Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses

Not Yet Recruiting
NCT05954104Not Applicable

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma

Completed
NCT05416320Early Phase 1

Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

Withdrawn
NCT03847441Not Applicable

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

Completed
NCT03848806Phase 2

Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Completed
NCT00358384Phase 1

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

Completed
NCT03069144Phase 1

Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Completed
NCT01646567Phase 1

SHP-141C in Plaque Type Psoriasis

Completed
NCT01763424Phase 2

Nicotinamide in the Treatment of Psoriasis

Completed
NCT00796211Phase 2

A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis

Completed
NCT00705900Not Applicable

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

Completed
NCT00445250Phase 2

The Role of Calcipotriol as Radioprotector of Skin

Unknown

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16